Type of securities : Common share | Effective Date : 21/06/2021 | Close Selling Date : 25/06/2021
ประเภทหลักทรัพย์ : หุ้นสามัญ | วันที่มีผลใช้บังคับ : 21/06/2564 | วันที่ปิดการขาย : 25/06/2564
44.19 million or 99.93%, which was in line with the sharp increase in revenues from sales in this period. Gross profit margin in Q2/2018 was 62.21%, a slight decrease by 0.61% year-on-year. The decline in
101.48 million or 65.46%, which was in line with the sharp rising in revenues from sales in this period. Gross profit margin in year 2018 was 61.51%, going up by 59.98% year-on-year. The growth in year
- 2. Cost of sales and gross profit The Company’s cost of sales in Q3/2018 amounted to Baht 57.43 million, rising year-on-year by Baht 25.81 million or 81.63%, which was in line with the sharp increase
decreased from Baht 67.0 million to be Baht 50.7 million or equivalent to 24.29%. Therefore, the gross profit margin in Q2/2017 was declined from 7.12% in Q2/2016 to be 5.78%. This was derived from the sharp
social distancing practices put in place to combat the viral transmission, which have posed a new challenge to our competitiveness, while we have sought new business opportunities to secure our status as a
billion from financial institutions to secure liquidity flexibility even if the COVID-19 crisis continues for long time. With the supply chain interruption from COVID-19 impact, scheduled commercial
WINMED May 11 2021 12:00AM 120000000 372 2025-01-09 2021 6 Security IPO SECURE Jul 1 2021 12:00AM 27741000 443.856 2025-01-09 2021 6 Security IPO SMD100 Jun 17 2021 12:00AM 54000000 388.8 2025-01-09 2021 7